Intrapartum antibiotic prophylaxis and early-onset neonatal sepsis patterns

Infectious Disease in Obstetrics and Gynecology

Volumn 11, Issue 4, 2003, Pages 221-226

  Edwards, Rodney K ^a,c   Jamie, Whitney E ^a   Sterner, Donald ^b   Gentry, Susan ^a   Counts, Kathy ^b   Duff, Patrick ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Antibiotic resistance; Group B streptococcus; Pregnancy; Staphylococci

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; ESCHERICHIA COLI; GESTATIONAL AGE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SEPSIS; PREMATURITY; PRIORITY JOURNAL; REVIEW; SCREENING TEST; STREPTOCOCCUS AGALACTIAE;

AMPICILLIN; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREVALENCE; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0346503115     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/10647440300025525     Document Type: Review

References (13)

1. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45:1-24
2. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. MMWR 2002;51:1-22.
3. Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9
4. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998;179: 879-83
5. Joseph TA, Pyati SP, Jacobs N. Neonatal early-onset Eschetichia coli disease: the effect of intrapartum ampicillin. Arch Pediatr Adolesc Med 1998;152:35-40
6. Levine EM, Ghai V, Barton JJ, Strom CM. Intrapartum antibiotic prophylaxis increases the incidence of Gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 1999;7:210-13
7. O'Reilly G, Hitti J, Brock B, Watts DH, Gill P, Benedetti T. Gram-negative sepsis among low-birth-weight infants: infection rates before and after initiation of group B streptococcus prophylaxis. Am J Obstet Gynecol 2001;184:S14
8. Chen KT, Tuomala RE, Cohen AP, Eichenwald EC, Lieberman E. No increase in rates of early-onset neonatal sepsis by non-group B Streptococcus or ampicillin-resistant organisms. Am J Obstet Gynecol 2001;185:854-8
9. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001;108:1094-8
10. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis, 1993-1998. N Engl J Med 2000;342:15-20
11. Locksmith GJ, Clark P, Duff P. Maternal and neonatal infection rates with three different protocols for prevention of group B streptococcal disease. Am J Obstet Gynecol 1999;180:416-22
12. Edwards RK, Clark P, Sistrom CL, Duff P. Intrapartum antibiotic prophylaxis. 1: relative effects of recommended antibiotics on Gram-negative pathogens. Obstet Gynecol 2002;100:534-9
13. Schuchat A. Group B streptococcal disease: from trials and tribulations to triumph and trepidation. Clin Infect Dis 2001;33:751-6